• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

PC1 Prospectus - $5m Placement26/03/13
PC1 Results of Meeting22/03/13
PC1 Suspension from Official QuotationPRICE SENSITIVE21/03/13
PC1 RM Research Report on Acuvax15/03/13
PC1 Corporate Presentation- Biolife Science Ltd13/03/13
PC1 Appendix 4D and Half Year Financial ReportPRICE SENSITIVE25/02/13
PC1 Despatch of Notice of Meeting/ Shareholder Letter21/02/13
PC1 Notice of Meeting/Proxy Form15/02/13
PC1 Binding Agreement to acquire Biolife Science LtdPRICE SENSITIVE12/02/13
PC1 Appendix 4C - quarterlyPRICE SENSITIVE31/01/13
PC1 Acquisition of cancer immunotherapy companyPRICE SENSITIVE20/12/12
PC1 Trading HaltPRICE SENSITIVE19/12/12
PC1 Results of Meeting29/11/12
PC1 Appendix 4C - quarterlyPRICE SENSITIVE29/10/12
PC1 Annual Report to shareholders25/10/12
PC1 Notice of Annual General Meeting/Proxy Form25/10/12
PC1 Director Appointment/Resignation -Appendix 3X/3Z17/10/12
PC1 Full Year Statutory Accounts24/09/12
PC1 Appendix 4E - Preliminary Final ReportPRICE SENSITIVE31/08/12
PC1 Appendix 4C - quarterlyPRICE SENSITIVE31/07/12
PC1 Completion of BioHealth AcquisitionPRICE SENSITIVE18/05/12
PC1 Ceasing to be a substantial holder04/05/12
PC1 Change in substantial holding03/05/12
PC1 Appendix 4C - quarterlyPRICE SENSITIVE30/04/12
PC1 Response to ASX volume queryPRICE SENSITIVE27/04/12
PC1 Half Year Financial Report and Appendix 4DPRICE SENSITIVE28/02/12
PC1 Unlisted Options expire13/02/12
PC1 Appendix 4C - quarterlyPRICE SENSITIVE31/01/12
PC1 Director Appointment/Resignation27/01/12
PC1 PROPOSED DIAGNOSTIC TECHNOLOGY ACQUISITIONPRICE SENSITIVE25/01/12
PC1 Proposed BioHealth AcquisitionPRICE SENSITIVE01/12/11
PC1 Results of AGM and New Constitution25/11/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE27/10/11
PC1 Annual Report to shareholders14/10/11
PC1 Notice of Annual General Meeting/Proxy Form14/10/11
PC1 Full Year Statutory Accounts29/09/11
PC1 Change in substantial holding08/09/11
PC1 Preliminary Final ReportPRICE SENSITIVE30/08/11
PC1 Becoming a substantial holder24/08/11
PC1 Revised Change of Director's Interest Notice22/08/11
PC1 Change in substantial holding22/08/11
PC1 Change of Director's Interest Notice19/08/11
PC1 Appendix 3B and Sec 708(A) notice16/08/11
PC1 Change of Director's Interest Notice02/08/11
PC1 Change of Company Details01/08/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE29/07/11
PC1 Appendix 3B and Section 708(A) Notice18/07/11
PC1 Results of Meeting07/07/11
PC1 Notice of General Meeting/Proxy Form07/06/11
PC1 Appendix 3B and Section 708(A) Notice03/06/11
PC1 Proposed capital raisingPRICE SENSITIVE27/05/11
PC1 Options Expired09/05/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE28/04/11
PC1 Corrected Results of Meeting25/03/11
PC1 Results of Meeting25/03/11
PC1 Appendix 4D - Half Yearly Report and AccountsPRICE SENSITIVE28/02/11
PC1 Notice of General Meeting/Proxy Form17/02/11
PC1 Director Resignation / Appendix 3Z08/02/11
PC1 Ceasing to be a substantial holder x302/02/11
PC1 Appendix 4C - quarterlyPRICE SENSITIVE31/01/11
PC1 Receipt of notice under sec249D28/01/11
PC1 Change in substantial holding15/12/10
PC1 Change in substantial holding15/12/10
PC1 Change in substantial holding15/12/10
PC1 Appendix 3B and sec 708A notice13/12/10
PC1 Becoming a substantial holder13/12/10
PC1 Change in substantial holding10/12/10
PC1 Appendix 3B and Sec708A notice09/12/10
PC1 Change in substantial holding03/12/10
PC1 Change in substantial holding03/12/10
PC1 Change in substantial holding03/12/10
PC1 Company Secretary Appointment/Resignation02/12/10
PC1 Results of Annual General Meeting30/11/10
PC1 Ceasing to be a substantial holder29/11/10
PC1 s708A Notice and Appendix 3B25/11/10
PC1 Initial Directors' Interest Notice x 224/11/10
PC1 Final Directors' Interest Notice x 224/11/10
PC1 Shortfall Placement, Directors Appointment / Resignation19/11/10
PC1 Receipt of notice under s249D16/11/10
PC1 Ceasing to be a substantial holder15/11/10
PC1 Updated share trading policy15/11/10
PC1 Becoming a substantial holder15/11/10
PC1 Becoming a substantial holder15/11/10
PC1 Becoming a substantial holder12/11/10
PC1 Becoming a substantial holder12/11/10
PC1 Notice of Annual General Meeting/Proxy Form27/10/10
PC1 Appendix 4C - quarterlyPRICE SENSITIVE27/10/10
PC1 Initial Director's Interest Notice - IM25/10/10
PC1 Final Director's Interest Notice - AB25/10/10
PC1 Director Appointment/Resignation21/10/10
PC1 Change in substantial holding14/10/10
PC1 Appendix 3B12/10/10
PC1 Annual Report to shareholders30/09/10
PC1 Non-Renounceable Rights Issue - Allotment24/09/10
PC1 s708A notice24/09/10
PC1 Non-Renounceable Rights Issue Results22/09/10
PC1 Appendix 3B22/09/10
PC1 Non-Renounceable Rights Issue Dispatch Confirmation07/09/10
PC1 Change in substantial holding31/08/10
PC1 Preliminary Financial ReportPRICE SENSITIVE30/08/10
PC1 Prospectus - $5m Placement
26/03/13
PC1 Results of Meeting
22/03/13
PC1 Suspension from Official Quotation
21/03/13PRICE SENSITIVE
PC1 RM Research Report on Acuvax
15/03/13
PC1 Corporate Presentation- Biolife Science Ltd
13/03/13
PC1 Appendix 4D and Half Year Financial Report
25/02/13PRICE SENSITIVE
PC1 Despatch of Notice of Meeting/ Shareholder Letter
21/02/13
PC1 Notice of Meeting/Proxy Form
15/02/13
PC1 Binding Agreement to acquire Biolife Science Ltd
12/02/13PRICE SENSITIVE
PC1 Appendix 4C - quarterly
31/01/13PRICE SENSITIVE
PC1 Acquisition of cancer immunotherapy company
20/12/12PRICE SENSITIVE
PC1 Trading Halt
19/12/12PRICE SENSITIVE
PC1 Results of Meeting
29/11/12
PC1 Appendix 4C - quarterly
29/10/12PRICE SENSITIVE
PC1 Annual Report to shareholders
25/10/12
PC1 Notice of Annual General Meeting/Proxy Form
25/10/12
PC1 Director Appointment/Resignation -Appendix 3X/3Z
17/10/12
PC1 Full Year Statutory Accounts
24/09/12
PC1 Appendix 4E - Preliminary Final Report
31/08/12PRICE SENSITIVE
PC1 Appendix 4C - quarterly
31/07/12PRICE SENSITIVE
PC1 Completion of BioHealth Acquisition
18/05/12PRICE SENSITIVE
PC1 Ceasing to be a substantial holder
04/05/12
PC1 Change in substantial holding
03/05/12
PC1 Appendix 4C - quarterly
30/04/12PRICE SENSITIVE
PC1 Response to ASX volume query
27/04/12PRICE SENSITIVE
PC1 Half Year Financial Report and Appendix 4D
28/02/12PRICE SENSITIVE
PC1 Unlisted Options expire
13/02/12
PC1 Appendix 4C - quarterly
31/01/12PRICE SENSITIVE
PC1 Director Appointment/Resignation
27/01/12
PC1 PROPOSED DIAGNOSTIC TECHNOLOGY ACQUISITION
25/01/12PRICE SENSITIVE
PC1 Proposed BioHealth Acquisition
01/12/11PRICE SENSITIVE
PC1 Results of AGM and New Constitution
25/11/11
PC1 Appendix 4C - quarterly
27/10/11PRICE SENSITIVE
PC1 Annual Report to shareholders
14/10/11
PC1 Notice of Annual General Meeting/Proxy Form
14/10/11
PC1 Full Year Statutory Accounts
29/09/11
PC1 Change in substantial holding
08/09/11
PC1 Preliminary Final Report
30/08/11PRICE SENSITIVE
PC1 Becoming a substantial holder
24/08/11
PC1 Revised Change of Director's Interest Notice
22/08/11
PC1 Change in substantial holding
22/08/11
PC1 Change of Director's Interest Notice
19/08/11
PC1 Appendix 3B and Sec 708(A) notice
16/08/11
PC1 Change of Director's Interest Notice
02/08/11
PC1 Change of Company Details
01/08/11
PC1 Appendix 4C - quarterly
29/07/11PRICE SENSITIVE
PC1 Appendix 3B and Section 708(A) Notice
18/07/11
PC1 Results of Meeting
07/07/11
PC1 Notice of General Meeting/Proxy Form
07/06/11
PC1 Appendix 3B and Section 708(A) Notice
03/06/11
PC1 Proposed capital raising
27/05/11PRICE SENSITIVE
PC1 Options Expired
09/05/11
PC1 Appendix 4C - quarterly
28/04/11PRICE SENSITIVE
PC1 Corrected Results of Meeting
25/03/11
PC1 Results of Meeting
25/03/11
PC1 Appendix 4D - Half Yearly Report and Accounts
28/02/11PRICE SENSITIVE
PC1 Notice of General Meeting/Proxy Form
17/02/11
PC1 Director Resignation / Appendix 3Z
08/02/11
PC1 Ceasing to be a substantial holder x3
02/02/11
PC1 Appendix 4C - quarterly
31/01/11PRICE SENSITIVE
PC1 Receipt of notice under sec249D
28/01/11
PC1 Change in substantial holding
15/12/10
PC1 Change in substantial holding
15/12/10
PC1 Change in substantial holding
15/12/10
PC1 Appendix 3B and sec 708A notice
13/12/10
PC1 Becoming a substantial holder
13/12/10
PC1 Change in substantial holding
10/12/10
PC1 Appendix 3B and Sec708A notice
09/12/10
PC1 Change in substantial holding
03/12/10
PC1 Change in substantial holding
03/12/10
PC1 Change in substantial holding
03/12/10
PC1 Company Secretary Appointment/Resignation
02/12/10
PC1 Results of Annual General Meeting
30/11/10
PC1 Ceasing to be a substantial holder
29/11/10
PC1 s708A Notice and Appendix 3B
25/11/10
PC1 Initial Directors' Interest Notice x 2
24/11/10
PC1 Final Directors' Interest Notice x 2
24/11/10
PC1 Shortfall Placement, Directors Appointment / Resignation
19/11/10
PC1 Receipt of notice under s249D
16/11/10
PC1 Ceasing to be a substantial holder
15/11/10
PC1 Updated share trading policy
15/11/10
PC1 Becoming a substantial holder
15/11/10
PC1 Becoming a substantial holder
15/11/10
PC1 Becoming a substantial holder
12/11/10
PC1 Becoming a substantial holder
12/11/10
PC1 Notice of Annual General Meeting/Proxy Form
27/10/10
PC1 Appendix 4C - quarterly
27/10/10PRICE SENSITIVE
PC1 Initial Director's Interest Notice - IM
25/10/10
PC1 Final Director's Interest Notice - AB
25/10/10
PC1 Director Appointment/Resignation
21/10/10
PC1 Change in substantial holding
14/10/10
PC1 Appendix 3B
12/10/10
PC1 Annual Report to shareholders
30/09/10
PC1 Non-Renounceable Rights Issue - Allotment
24/09/10
PC1 s708A notice
24/09/10
PC1 Non-Renounceable Rights Issue Results
22/09/10
PC1 Appendix 3B
22/09/10
PC1 Non-Renounceable Rights Issue Dispatch Confirmation
07/09/10
PC1 Change in substantial holding
31/08/10
PC1 Preliminary Financial Report
30/08/10PRICE SENSITIVE
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.